Stifel Backs Cooper Companies (COO) as CooperSurgical Sale Talks Progress

Wait 5 sec.

Skip to navigationSkip to main contentSkip to right columnADVERTISEMENTAbdul RahmanFri, June 26, 2026 at 7:50 PM GMT+2 2 min readCooper Companies Inc (NASDAQ:COO) is one of the best stocks to buy according to Billionaire Barry Rosenstein. This stock is backed by 49 hedge funds, and analysts see the stock rising at least 17% from its current price in the next 12 months.Stifel Estimates Cooper Companies Inc (COO) Stock Price After Unit SaleOn June 12, Stifel reiterated a Buy rating on Cooper Companies Inc (NASDAQ:COO) stock with a price target of $85 on the shares. The brokerage made this call after Cooper reported advancing discussions to sell its surgical business unit known as CooperSurgical. The company said multiple parties are interested in buying the business. The company also settled all legal issues that had plagued the business unit.Stifel remarked that the settlement is a signal that the management is advancing the unit sale talks to the next level. Selling CooperSurgical would leave Cooper focused on the contact lens business under its CooperVision unit.After CooperSurgical is divested and Cooper transforms into a contact lens company, Stifel estimates that Cooper stock could be worth $80 a share. This indicates a roughly 21% upside to the current share price. Cooper CEO Albert White has said that the vast majority of the proceeds from the sale of the surgical business would be used to fund share repurchases.Cooper Companies Inc (NASDAQ:COO) is a medical devices company. It operates two main business divisions: CooperVision and CooperSurgical. The CooperVision unit makes contact lenses to correct vision challenges. The CooperSurgical division is focused on women's health and provides genetic testing and fertility products.While we acknowledge the potential of COO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.READ NEXT: 10 Most Promising Healthcare Stocks According to Wall Street Analysts and 15 High-Growth Large-Cap Stocks to Invest In Now.Disclosure: None. Follow Insider Monkey on Google News.Terms and Privacy PolicyEU DSA contactPrivacy & Cookie SettingsMore Info